This content is machine translated Diabetes mellitus Treatment of comorbidities in older people One in five people over 65 and one in four people over 75 are affected by diabetes. Global projections predict a 2.5-fold increase in diabetes prevalence over the next 25...… CME-Test
View Post 15 min This content is machine translated Diabetes mellitus Treatment of comorbidities in older people One in five people over 65 and one in four people over 75 are affected by diabetes. Global projections predict a 2.5-fold increase in diabetes prevalence over the next 25...… CME-Test
View Post 6 min This content is machine translated Update 2025 Hypercholesterolemia The past 18 months have noticeably shifted the LDL-lowering landscape: An ESC/EAS-Focused Update 2025 sharpens the indication thresholds, real-world data confirm the benefit of early combinations after myocardial infarction, bempedoic...…
View Post 8 min This content is machine translated HFpEF 2025 Precision medicine and phenotypes In 2025, heart failure with preserved ejection fraction (HFpEF) is less than ever a single clinical picture – it is an umbrella over many phenotypes with different triggers, pathomechanisms and...…
View Post 15 min This content is machine translated Pulmonary hypertension PH and lung diseases Pulmonary hypertension (PH) describes a hemodynamic condition with a pathological increase in pressure in the pulmonary vascular circulation. Clinically, PH causes reduced performance, shortness of breath, angina and syncope. Comprehensive...… CME-Test
View Post 8 min This content is machine translated A syndrome between decompensation and chronification Worsening Heart Failure The deterioration of chronic heart failure – so-called worsening heart failure (WHF) – is no longer solely an acute event, but an expression of complex, often repetitive pathophysiological dynamics. Despite...…
View Post 8 min This content is machine translated Cardiogenic shock - 2025 update Between standardization, team processes and targeted cycle support Cardiogenic shock (CS) is and remains the most dramatic form of acute circulatory failure in cardiology. Despite decades of intensive research, hospital mortality has long remained in the range of...…
View Post 9 min This content is machine translated Catheter ablation for atrial fibrillation 2025 Pulsed field versus radio frequency – where do we stand? In the treatment of atrial fibrillation (AF), catheter ablation has developed from a specialized option to the mainstay of a modern rhythm strategy within a decade. In 2025, two developments...…
View Post 10 min This content is machine translated From the late residual valve to independent therapy Tricuspid interventions 2025 For a long time, the tricuspid valve was considered the “forgotten valve”. In 2025, there is nothing left of it. Within just a few years, an independent, evidence-based field has...…
View Post 11 min This content is machine translated Late-Breaking Science Antithrombotics & rhythm The ESC Congress 2025 in Madrid presented several studies in hot-line and late-breaking sessions that have a direct impact on the care of patients with atrial fibrillation, coronary heart disease,...…
View Post 6 min This content is machine translated AI-supported imaging and new biomarkers CHD diagnostics update Coronary heart disease remains one of the key challenges in cardiology. However, the way in which it is diagnosed is changing rapidly. Computed tomographic coronary angiography (CCTA), fractional flow reserve...…
